AUSTIN, Texas, June 4, 2026 /PRNewswire/ -- Communication Service for the Deaf (CSD) announced today that it has appointed Karen Peltz Strauss to its...
The Arizona residential treatment center introduces broader awareness of its trauma-informed and salutogenic recovery model through Forward-Facing® Accelerated Recovery
The Arizona residential treatment center introduces broader awareness of its trauma-informed and salutogenic recovery model through Forward-Facing® Accelerated Recovery
European Pension Investors Back Strategy Focused on Korea's Rapidly Expanding Rental Housing MarketNEW YORK, June 4, 2026 /PRNewswire/ -- Tishman Speyer today announced the...
DOWNERS GROVE, Ill., June 4, 2026 /PRNewswire/ -- Univar Solutions, LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of...
DOWNERS GROVE, Ill., June 4, 2026 /CNW/ -- Univar Solutions, LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of...
DOWNERS GROVE, Ill., June 4, 2026 /PRNewswire/ -- Univar Solutions, LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of...
BANGKOK, June 4, 2026 /PRNewswire/ -- Delta Electronics (Thailand) Public Company Limited, a global leader in power management and smart green solutions, is presenting...
GOTHENBURG, Sweden, June 4, 2026 /PRNewswire/ -- Volvo Autonomous Solutions (V.A.S.) and Boliden have completed the autonomous transport project at Boliden's Garpenberg site in...
TAIPEI, June 4, 2026 /PRNewswire/ -- Compal Electronics (Compal; TWSE: 2324) showcases its landmark achievements in Quantum Technology and Advanced Artificial Intelligence (AI) at COMPUTEX...
SINGAPORE, June 4, 2026 /PRNewswire/ -- Synology is unveiling its latest innovations at COMPUTEX 2026, featuring a comprehensive portfolio of AI-enhanced solutions spanning the...
MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.